Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
211 hedge funds and large institutions have $1.12B invested in Immunogen Inc in 2020 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 56 increasing their positions, 72 reducing their positions, and 18 closing their positions.
144% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 18
119% more capital invested
Capital invested by funds: $512M → $1.12B (+$609M)
14% more funds holding
Funds holding: 185 → 211 (+26)
4% less call options, than puts
Call options by funds: $3.91M | Put options by funds: $4.09M
22% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 72
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$66.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$64M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$20.5M |
| 4 |
Morgan Stanley
New York
|
+$16.6M |
| 5 |
O
OrbiMed
New York
|
+$14.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$18M |
| 2 |
Millennium Management
New York
|
-$16.3M |
| 3 |
Renaissance Technologies
New York
|
-$13.1M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$6.25M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.81M |
IMGN Hedge Fund Activity: Q4 2020 in Review
211 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2020, worth a combined $1.12B — up 119% from $512M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new IMGN positions and 18 closed out — a net gain of 26 holders — while 56 added to existing stakes and 72 trimmed.
The largest buyer was RA Capital Management, adding an estimated $66.4M. The largest seller was Assenagon Asset Management, exiting entirely with an estimated $18M sold.
- 211 institutional investors held Immunogen Inc (IMGN) as of Q4 2020, up from 185 in Q3 2020.
- Funds reported $1.12B of Immunogen Inc stock for Q4 2020, up 119% quarter-over-quarter.
- 44 funds opened new Immunogen Inc positions in Q4 2020 and 18 closed out, a net change of +26 holders.
- The largest Immunogen Inc buyer in Q4 2020 was RA Capital Management, an estimated $66.4M added.
- The largest Immunogen Inc seller in Q4 2020 was Assenagon Asset Management, an estimated $18M sold.
Based on aggregated 13F filings for Q4 2020.